INmune Bio (INMB) Earnings Date, Estimates & Call Transcripts → A New Generation of Billionaires Is About to Be Created (From Banyan Hill Publishing) (Ad) Free INMB Stock Alerts $8.83 -0.56 (-5.96%) (As of 01:49 PM ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 5EstimatedActual EPS (May. 9) -$0.61 Missed By -$0.61 Read Call TranscriptListen to Call Get INmune Bio Earnings AlertsEnter your email address below to receive the latest news and earnings results for INMB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueINMB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.INMB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Brooks EnterprisesWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, was terrible! The majority of market indexes lost over 50% of their value. Almost every day, traders would look at their trading accounts and just see a sea of red.Get those kind of results during the Great Financial Crisis, without having to study more INMB Earnings Date and InformationINmune Bio last announced its quarterly earnings results on May 9th, 2024. The reported ($0.61) EPS for the quarter. The firm earned $0.01 million during the quarter. INmune Bio has generated ($1.92) earnings per share over the last year (($1.92) diluted earnings per share). INmune Bio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off prior year's report dates.Read More INmune Bio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/5/2024(Estimated)------- 5/9/2024Q1 2024-($0.61)($0.61)($0.61)-$0.01 million 3/28/2024Q4 2023-($0.47)($0.47)($0.47)-$0.03 million11/1/2023Q3 2023-($0.48)($0.48)($0.48)-$0.04 million8/7/2023Q2 2023-($0.36)($0.36)($0.36)-$0.05 million5/3/2023Q1 2023-($0.36)($0.36)($0.36)-$0.04 million3/2/2023Q4 2022-($0.32)($0.32)($0.32)-$0.10 million Get the Latest News and Ratings for INMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INmune Bio and its competitors with MarketBeat's FREE daily newsletter. 11/2/2022Q3 2022($0.59)($0.43)+$0.16($0.43)-$0.10 million8/3/2022Q2 2022($0.50)($0.38)+$0.12($0.38)-$0.02 million 5/5/2022Q1 2022($0.60)($0.39)+$0.21($0.39)-$0.16 million 3/3/2022Q4 2021($0.56)($0.55)+$0.01($0.55)-$0.16 million 11/2/2021Q3 2021($0.43)($0.55)($0.12)($0.55)-$0.01 million 8/3/2021Q2 2021($0.34)($0.44)($0.10)($0.44)-- 5/4/2021Q1 2021($0.27)($0.32)($0.05)($0.32)-- 3/3/2021Q4 2020($0.31)($0.26)+$0.05($0.24)-$0.01 million 11/5/2020Q3 2020($0.17)($0.36)($0.19)($0.36)--8/5/2020Q2 2020($0.20)($0.20)-($0.20)--5/14/2020Q1 2020($0.21)($0.19)+$0.02($0.19)-- 3/11/2020Q4 2019($0.25)($0.22)+$0.03($0.22)-- 11/8/2019Q3($0.1930)($0.28)($0.0870)($0.28)--8/12/2019Q2 2019($0.20)($0.04)+$0.16($0.04)-- INmune Bio Earnings - Frequently Asked Questions When is INmune Bio's earnings date? INmune Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates. Learn more on INMB's earnings history. How can I listen to INmune Bio's earnings conference call? The conference call for INmune Bio's latest earnings report can be listened to online. Listen to Conference Call How can I read INmune Bio's conference call transcript? The conference call transcript for INmune Bio's latest earnings report can be read online. Read Transcript How much revenue does INmune Bio generate each year? INmune Bio (NASDAQ:INMB) has a recorded annual revenue of $160,000.00. How much profit does INmune Bio generate each year? INmune Bio (NASDAQ:INMB) has a recorded net income of -$30.01 million. INMB has generated -$1.92 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: XFOR Earnings Date CDTX Earnings Date FBIO Earnings Date PRME Earnings Date RGNX Earnings Date CRGX Earnings Date HLVX Earnings Date ITOS Earnings Date TSHA Earnings Date VALN Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:INMB) was last updated on 6/6/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredEverything from semiconductors to space shuttles depend on this overlooked mineralBoron is also at the heart of a breakthrough that could fuel one of mankind's most sensational advances in sem...Capital Trends | Sponsored[Webinar] Understanding Covered CallsDiscover the details of this option-selling strategy.OIC | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredThe Most Dangerous Time for 401k OwnersThe world's most powerful CEO just issued a grave warning to Americans... "This may be the most dangerous t...Birch Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INmune Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INmune Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.